<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-O4PFO30R</identifier><date>2015</date><creator>Borštnar, Simona</creator><relation>documents/doc/O/URN_NBN_SI_doc-O4PFO30R_001.pdf</relation><relation>documents/doc/O/URN_NBN_SI_doc-O4PFO30R_001.txt</relation><format format_type="issue">3</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 245-249</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">281600768</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-O4PFO30R</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">breast</subject><subject language_type_id="slv">dojke</subject><subject language_type_id="slv">monoklonska protitelesa</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Monoclonal antibodies for the treatment of breast cancer</title><title>Monoklonska protitelesa v zdravljenju raka dojk</title></Record>